MedPath

Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent Injection

Recruiting
Conditions
Crohn Disease
Interventions
Device: MRI
Registration Number
NCT06526234
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

Entero-MRI is indicated in Crohn's disease as part of the initial work-up or follow-up (to assess response to treatment, complications). The protocol for carrying out the examination complies with precise specifications set out in international recommendations. To perform the test, the small intestine must be distended with a hyperosmolar product. This protocol is applied to all patients, with no distinction or adaptation.

The total duration of the examination is sometimes difficult for patients to bear. Ingestion of the product to obtain distension of the small intestine is often poorly tolerated by patients.

In a number of cases, the entero-MRI may have been normal due to symptomatology regression or other diagnosis. The patient therefore underwent a complete examination similar to that of a patient with a pathology requiring characterization.

In this context, the investigators hypothesize that fast MR sequences are sufficient to discriminate between normal and abnormal examinations.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria

Patient with MR enterography examination for follow-up or suspected Crohn's disease

No Exclusion Criteria.

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with Crohn's disease or suspected Crohn's diseaseMRI-
Primary Outcome Measures
NameTimeMethod
Presence or absence of lesions detected visually by a radiologist on injection-free sequences versus conventional MR enterography.Baseline (day 0)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHRU Nancy

🇫🇷

Vandœuvre-lès-Nancy, CHRU De Nancy, France

© Copyright 2025. All Rights Reserved by MedPath